ArticleThe Medical journal of Australia2025
Evaluating the impact of COVID-19 vaccination strategies on infections and hospitalisations in Victoria with non-seasonal epidemic wave patterns: a modelling study.
Article in The Medical journal of Australia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesTo assess the impact of different coronavirus disease 2019 (COVID-19) vaccination strategies on infections and hospitalisations in the context of non-seasonal epidemic waves. STUDY
designDynamic compartmental model-based analysis.
settingVictoria (Australia).
interventionAlternative COVID-19 vaccination strategies: baseline (low population coverage - 18-64 years, 7%; 65 years or older, 44% - vaccinations distributed evenly across the year); high coverage for all age groups, with vaccinations spread across year; increased coverage for people aged 65 years or older; annual vaccination campaigns that achieve coverage equivalent to that of influenza vaccinations (18-64 years, 25%; 65 years or older, 59%), commencing in March (same time as influenza vaccination campaign), August, or December; no further COVID-19 vaccinations for people under 65 years of age; no further COVID-19 vaccinations for anyone. Vaccination scenarios used different assumptions about COVID-19 epidemic wave periodicity, and peak infections magnitude and month.
main outcome measuresMean incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and COVID-19-related hospitalisations over a ten-year projection period.
resultsThe low baseline population level of recent COVID-19 vaccination means that any increase in coverage could reduce infection and hospitalisation incidence. Increasing COVID-19 vaccination coverage to match that of influenza vaccination with an annual vaccination campaign reduced the mean incidence of infections by 1-13% and that of hospitalisations by 3-14%, depending on the timing of vaccination campaigns with respect to the epidemic infections peak and assumptions about epidemic wave characteristics. Increasing coverage for people aged 65 years or older reduced hospitalisation incidence by 9-26%, but required twice as many vaccine doses as the annual campaign strategies.
conclusionsAnnual COVID-19 vaccination campaigns at the same time as those for influenza vaccination could reduce the number of COVID-19-related hospitalisations, with lower logistical requirements than alternative approaches.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.